Future of an ‘asymptomatic’ T-cell epitope-based therapeutic herpes simplex vaccine

Efficacy Results of a Trial of a Herpes Simplex Vaccine

(2012) Robert B. Belshe et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genital Shedding of Herpes Simplex Virus Among Symptomatic and Asymptomatic Persons With HSV-2 Infection

(2011) Elizabeth Tronstein   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

HSV-2: in pursuit of a vaccine

(2011) Christine Johnston et al.   JOURNAL OF CLINICAL INVESTIGATION

C21orf91 Genotypes Correlate With Herpes Simplex Labialis (Cold Sore) Frequency: Description of a Cold Sore Susceptibility Gene

(2011) John D. Kriesel et al.   JOURNAL OF INFECTIOUS DISEASES

The Herpes Simplex Virus 1 Latency-Associated Transcript Promotes Functional Exhaustion of Virus-Specific CD8+ T Cells in Latently Infected Trigeminal Ganglia: a Novel Immune Evasion Mechanism

(2011) A. A. Chentoufi et al.   JOURNAL OF VIROLOGY

Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes

(2011) David W. Kimberlin et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Live-Attenuated HSV-2 ICP0− Virus Elicits 10 to 100 Times Greater Protection against Genital Herpes than a Glycoprotein D Subunit Vaccine

(2011) William P. Halford et al.   PLoS One

Of mice and not humans: How reliable are animal models for evaluation of herpes CD8+-T cell-epitopes-based immunotherapeutic vaccine candidates?

(2011) Gargi Dasgupta et al.   VACCINE

Nasolacrimal Duct Closure Modulates Ocular Mucosal and Systemic CD4+ T-Cell Responses Induced following Topical Ocular or Intranasal Immunization

(2010) A. A. Chentoufi et al.   Clinical and Vaccine Immunology

Zoster Vaccine: Current Status and Future Prospects

(2010) Michael N. Oxman   CLINICAL INFECTIOUS DISEASES

Future viral vectors for the delivery of asymptomatic herpes epitope-based immunotherapeutic vaccines

(2010) Aziz Alami Chentoufi et al.   Future Virology

A Novel HLA (HLA-A*0201) Transgenic Rabbit Model for Preclinical Evaluation of Human CD8 + T Cell Epitope-Based Vaccines against Ocular Herpes

(2010) Aziz A. Chentoufi et al.   JOURNAL OF IMMUNOLOGY

Herpes Simplex Virus 2 ICP0− Mutant Viruses Are Avirulent and Immunogenic: Implications for a Genital Herpes Vaccine

(2010) William P. Halford et al.   PLoS One

Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein

(2010) Natalia J. Reszka et al.   VACCINE

Developing an asymptomatic mucosal herpes vaccine: the present and the future

(2009) Gargi Dasgupta et al.   Future Microbiology

Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection

(2009) W. J. Muller et al.   JOURNAL OF GENERAL VIROLOGY

Varicella‐Zoster Virus–Specific Immune Responses to Herpes Zoster in Elderly Participants in a Trial of a Clinically Effective Zoster Vaccine

(2009) Adriana Weinberg et al.   JOURNAL OF INFECTIOUS DISEASES

A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge

(2009) X Zhang et al.   Mucosal Immunology

Maternal and Neonatal Herpes Simplex Virus Infections

(2009) Lawrence Corey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Recombinant Listeria monocytogenes expressing an immunodominant peptide fails to protect after intravaginal challenge with herpes simplex virus-2

(2008) William J. Muller et al.   ARCHIVES OF VIROLOGY

Does asymptomatic shedding of herpes simplex virus on the ocular surface lead to false-positive diagnostic PCR results?

(2008) J. F. Leigh et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection

(2008) Katharine Looker   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Gender-Dependent HLA-DR-Restricted Epitopes Identified from Herpes Simplex Virus Type 1 Glycoprotein D

(2008) X. Zhang et al.   Clinical and Vaccine Immunology

Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B

(2008) A. A. Chentoufi et al.   JOURNAL OF VIROLOGY

Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys

(2008) Jinyan Liu et al.   NATURE

Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigs

(2008) Yo Hoshino et al.   VACCINE

The number of herpes simplex virus-infected neurons and the number of viral genome copies per neuron correlate with the latent viral load in ganglia

(2007) Yo Hoshino et al.   VIROLOGY

Disruption of the UL41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes

(2007) Timothy Dudek et al.   VIROLOGY